Status:
UNKNOWN
A Retrospective Cohort Study of HFRS
Lead Sponsor:
Tongji Hospital
Conditions:
HFRS
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this retrospective cohort study is to learn about the clinial characteristics of HFRS patients, explore the risk factors of the occurrence and death of HFRS, and build a risk prediction mo...
Detailed Description
HFRS remains an important public health issue in China, which not only poses a threat to people's physical health and safety, but also has a serious impact on social and economic development. At prese...
Eligibility Criteria
Inclusion
- The patients must meet all of the following criteria:
- Inpatient with clinical diagnosis of Haemorrhagic Fever with Renal Syndrome
Exclusion
- Exclude patients who meet any of the following criteria:
- Patients with previous chronic kidney disease
- Pregnant or perinatal patients
- Patients unsuitable for inclusion by investigators' evaluation
Key Trial Info
Start Date :
May 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06020326
Start Date
May 5 2022
End Date
December 31 2023
Last Update
August 31 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
No.1 Peoples Hospital of Guangshui
Guangshui, Hubei, China
2
Huanggang Central Hospital
Huanggang, Hubei, China
3
People's Hospital of Luotian County
Huanggang, Hubei, China
4
People's Hospital of Macheng City, Affiliated Hospital of Hubei University of Science and Technology
Macheng, Hubei, China